Profound Medical Corp.
Index- P/E- EPS (ttm)-1.39 Insider Own2.00% Shs Outstand20.77M Perf Week-1.44%
Market Cap142.27M Forward P/E- EPS next Y-0.99 Insider Trans0.00% Shs Float19.13M Perf Month-14.48%
Income- PEG- EPS next Q-0.34 Inst Own52.33% Short Float3.34% Perf Quarter-27.97%
Sales8.76M P/S16.25 EPS this Y4.80% Inst Trans- Short Ratio11.73 Perf Half Y-42.63%
Book/sh4.24 P/B1.62 EPS next Y16.80% ROA- Target Price- Perf Year-63.41%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range6.09 - 19.32 Perf YTD-39.00%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-64.54% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low12.48% ATR0.56
Employees109 Current Ratio- Sales Q/Q13.40% Oper. Margin- RSI (14)41.77 Volatility6.09% 7.83%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.43 Prev Close7.06
ShortableYes LT Debt/Eq- EarningsMay 09 AMC Payout- Avg Volume54.51K Price6.85
Recom1.50 SMA20-6.35% SMA50-16.44% SMA200-39.36% Volume23,676 Change-2.97%
Sep-15-20Initiated Jefferies Buy
May-18-22 05:43PM  
May-17-22 05:25PM  
May-15-22 08:08AM  
May-09-22 04:05PM  
Apr-25-22 04:30PM  
Apr-18-22 04:30PM  
Mar-04-22 04:48AM  
Mar-03-22 04:03PM  
Mar-02-22 08:00AM  
Mar-01-22 07:00AM  
Feb-24-22 03:00PM  
Feb-10-22 04:30PM  
Feb-08-22 04:30PM  
Jan-18-22 07:48AM  
Jan-05-22 08:00AM  
Dec-03-21 12:23PM  
Nov-04-21 04:03PM  
Nov-01-21 04:30PM  
Oct-28-21 03:05PM  
Oct-18-21 04:45PM  
Oct-04-21 09:02AM  
Sep-08-21 04:30PM  
Aug-19-21 10:41AM  
Aug-04-21 04:05PM  
Jul-28-21 03:03PM  
Jul-22-21 04:30PM  
Jul-15-21 04:30PM  
Jul-05-21 08:36AM  
May-25-21 04:30PM  
May-20-21 03:20AM  
May-12-21 04:13PM  
May-06-21 07:00AM  
May-05-21 03:00PM  
Apr-21-21 04:30PM  
Apr-14-21 04:30PM  
Apr-05-21 06:18AM  
Mar-03-21 07:00AM  
Mar-02-21 04:02PM  
Feb-25-21 04:30PM  
Feb-17-21 06:34AM  
Feb-11-21 04:30PM  
Feb-09-21 04:30PM  
Jan-05-21 04:30PM  
Jan-01-21 02:23AM  
Dec-21-20 07:30AM  
Dec-14-20 10:46AM  
Nov-30-20 08:00AM  
Nov-10-20 04:30PM  
Nov-05-20 04:02PM  
Oct-15-20 04:30PM  
Oct-05-20 02:22PM  
Sep-09-20 04:30PM  
Aug-10-20 08:00AM  
Aug-06-20 04:02PM  
Aug-05-20 02:29PM  
Jul-22-20 08:00AM  
Jul-21-20 12:35PM  
Jul-15-20 08:58PM  
Jul-01-20 08:32AM  
Jun-21-20 11:04PM  
May-20-20 04:30PM  
May-11-20 08:47AM  
May-07-20 04:02PM  
Apr-30-20 12:34PM  
Apr-21-20 12:31AM  
Apr-16-20 04:30PM  
Apr-02-20 02:55PM  
Mar-03-20 04:03PM  
Mar-01-20 02:36AM  
Feb-26-20 08:00AM  
Feb-12-20 08:00AM  
Feb-04-20 04:30PM  
Jan-27-20 11:05AM  
Jan-23-20 12:06AM  
Jan-22-20 08:55AM  
Jan-21-20 04:01PM  
Jan-10-20 07:30AM  
Dec-16-19 01:00PM  
Nov-18-19 03:54AM  
Nov-08-19 02:06PM  
Oct-31-19 08:30AM  
Oct-10-19 05:08AM  
Sep-09-19 02:05AM  
Aug-21-19 12:38AM  
Aug-03-19 03:49AM  
Jun-26-19 05:30AM  
Jun-07-19 02:21AM  
Apr-22-19 07:23AM  
Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.